Bloodstream infections result in approximately 1,200, 000 episodes and 157, 000 deaths annually in Europe.
Staphylococcus aureus (SA) and methicillin-resistant S. aureus (MRSA) continue to be leading causes of bloodstream infections, and are associated with increased patient of length of stay and hospital costs.
Current culture-based lab testing methods for gram positive blood culture bottles require an additional 24–72 hours for determination of SA or MRSA.
Without timely results, clinicians often employ empiric treatments, using costly and inadequate antimicrobials that contribute to increased drug resistance and worsened patient outcomes
The Solution
The Xpert MRSA/SA Blood Culture test is a qualitative in vitro diagnostic test designed for rapid and simultaneous detection of S. aureus and methicillin-resistant S. aureus (MRSA) directly from gram-positive blood cultures.
The Xpert MRSA/SA Blood Culture test delivers:
Efficient laboratories with on-demand workflows that require minimal hands-on time
Optimized therapy with fast informed treatment decisions to help reduce empirical prescribing
The Impact
Reduced result reporting turnaround time median of 24 hours, enabling earlier patient management review2
Enable earlier treatment with faster time to results3